Kodatef
Tafenoquine · Tablet, Film Coated · Oral
Uses
Malaria prophylaxis, consistent with the approved use of ARAKODA
Dosage and administration
Loading Dose: 200 mg (two of the 100 mg filmcoated tablets) once daily for three days. Maintenance Dose: 200 mg (two of the 100 mg filmcoated tablets) once weekly – start seven days after the last loading dose.
Warnings and precautions
Hemolytic Anemia G6PD Deficiency in Pregnancy and Lactation Methemoglobinemia Psychiatric Effects Hypersensitivity Reactions Delayed Adverse Reactions, Including Hemolytic Anemia, Methemoglobinemia, Psychiatric Effects, and Hypersensitivity Reactions
Label text from the FDA structured product label by 60 Degrees Pharmaceuticals, INC (revised Feb 10, 2025). Long sections are shortened; the complete label is on DailyMed.
Active ingredients
- Tafenoquine in 1 product
Kodatef NDC products (1)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 71475-258 | Tafenoquine 100 mg/1 Tablet, Film Coated | 60 Degrees Pharmaceuticals, INC | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
Frequently asked questions
What is Kodatef used for?
Malaria prophylaxis, consistent with the approved use of ARAKODA
Who makes Kodatef?
Kodatef is listed by 1 labeler in the FDA NDC directory, including 60 Degrees Pharmaceuticals, INC.